Advapro Coronary Stent System in Coronary Artery Diseased Patients.

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 120 participants.

Also called NCT06300268

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Advanced MedTech Solutions Pvt. Ltd. (from the registry)
Registry
  • NCT NCT06300268
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06300268. Allocation not applicable; no masking; primary purpose treatment. Start 2024-06 (anticipated); primary completion 2026-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Advapro Coronary Stent System in Coronary Artery Diseased Patients.
Acronym
RESTORE
Condition
De Novo Stenosis Lesion
Condition
Coronary Stent Implantation
Intervention (Device)
AdvaPro Sirolimus Eluting Coronary Stent System
Lead sponsor
Advanced MedTech Solutions Pvt. Ltd. (class: other)

Record details

Record id
cardio:ct-nct06300268
Content hash
99641188d3eb26f1c21733dccbd5fd5abe0b14123493af8d440c244ba86a64c6